Health News

Sysmex Inostics y Bayer HealthCare colaboran en el desarrollo de pruebas diagnósticas en sangre para terapias antitumorales dirigidas

Author: Australian Business

HAMBURGO, Alemania, October 15, 2013 /PRNewswire/ -- Sysmex Inostics, empresa filial de Sysmex Corporation, ha anunciado hoy un acuerdo marco de colaboración con Bayer HealthCare, para el desarrollo de test "Companion Diagnostics" para terapias antitumorales dirigidas. Esta......

More...

More Articles...

Janssen Submits Marketing Authorisation Application to European Medicines Agency for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat
Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone)
CMC Biologics Achieves Authorization for cGMP Commercial Manufacturing by the Danish Medicines Agency
TPI Auditor Change Updates
Immune Pharmaceuticals Announces Changes to its Board of Directors
IBM Research Unveils Two New Watson Related Projects from Cleveland Clinic Collaboration
Baylor College of Medicine Researchers Find Community-Based Weight Loss Intervention Yields Greater Weight Loss than Self-Help Approach
The Dentistry at West Hills Smiles Includes Invaluable Restorative and Cosmetic Procedures
Houston Pathologist Named Pathologist Of The Year
The Best Treatment for Weight Loss is Found Right Here in the U.S.

Page 934 of 1906